Share Prices & Company Research

Stockbroking

Nuformix

Current Price 7.20p Bid 7.00p Ask 7.50p Change 19.01%
Last Updated: 21/09/2019 07:41. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Nuformix plc (formerly Leverrett plc) is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs. Nuformix's risk-mitigated development strategy has resulted in a pipeline of discoveries through which it has developed and patented novel cocrystal forms of approved small molecules. Nuformix has created an IP portfolio of granted patents covering cocrystal forms of five small molecule drugs. Nuformix is targeting high-value unmet needs with its lead programmes in oncology supportive care: NXP001 and fibrosis: NXP002.

Financial Highlights Year Ended 31/03/2019

Turnover
£0.61m
Operating Profit
£-1.81m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-16.81

Key Personnel

Dr Daniel John Gooding
Chief Executive Officer
Joanne Holland
Chief Scientific Officer
Kirk Douglas Siderman-Wolter
Finance Director
Dr David Joszef Tapolczay
Non-Executive Chairman
Prof Francis John Lidgey
Non-Executive Director
Dr Christopher Paul Blackwell
Non-Executive Director

Stock Details

EPIC
NFX
ISIN
GB00BYW79Y38
Shares in Issue
469,466,512
Market cap
£28.40m
Sector

Analyst Views (0)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
0.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
7.20p
Bid Price
7.00p
Ask Price
7.50p
Volume
3337627
Change Today
1.15p
% Change Today
19.01%
Open
6.19p
Previous Close
7.20p
Intraday High
7.79p
Intraday Low
6.19p
52 Week High
14.75p
52 Week Low
1.93p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Nuformix Intra-day Chart

Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Tangible Assets
0.0
0.0
Intangible Assets & Goodwill
4.3
4.3
Investments & Other Non-Current Assets
0.0
0.0
Total Non-Current Assets
4.3
4.3
Inventory
0.0
0.0
Trade & Receivables
0.2
0.2
Cash & Receivables
0.0
0.3
Other Current Assets & Assets Held for Resale
0.2
0.2
Total Assets
4.6
5.0

Liabilities (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Short Term Liabilities
0.8
0.5
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
0.8
0.5

Net Assets (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Net Assets
3.8
4.5

Equity (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Share Capital
0.5
0.5
Minority Interests
0.0
0.0
Retained Earnings
-4.2
-2.6
Share Premium Account
2.9
2.9
Other Equity
4.7
3.7
Total Equity
3.8
4.5

Cashflow (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Cashflow from Operating Activities
-0.3
-1.5
Cashflow Before Financing
-0.3
-1.6
Increase / Decrease in Cash
-0.3
0.3

Income (£m)

Data has been provided by AJ Bell

Reporting Date
31 Mar 2019
31 Mar 2018
Turnover
0.6
0.0
Cost of Sales
0.5
0.2
Gross Profit
0.1
-0.2
Operating Profit
-1.8
-2.0
Pre-Tax Profit
-1.8
-2.0
Profit / Loss for the Year
-1.7
-1.8
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.